Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Palese

Showing results (221-230 of 291) with videos related to

Pageof 30
Sort By:
The Journal of Clinical Investigation|September 7, 2018
Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominanceSean T H Liu, Mohammad Amin Behzadi, Weina Sun, et al.
Journal of Virology|December 16, 2014
The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxADavid Riegger, Rong Hai, Dominik Dornfeld, et al.
Journal of Virology|May 3, 2019
Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope ProteinMark J Bailey, Felix Broecker, Alec W Freyn, et al.
Journal of Virology|November 12, 2005
Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in miceTerrence M Tumpey, Adolfo García-Sastre, Jeffery K Taubenberger, et al.
Nature Immunology|February 14, 2017
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteinsRaffael Nachbagauer, Angela Choi, Ariana Hirsh, et al.
Mbio|June 15, 2021
An Egg-Derived Sulfated <i>N</i>-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus VaccinesJenna J Guthmiller, Henry A Utset, Carole Henry, et al.
Vaccine|December 12, 2024
A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challengeStefan Slamanig, Nicholas Lemus, Tsoi Ying Lai, et al.
Nature|September 29, 2006
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virusJohn C Kash, Terrence M Tumpey, Sean C Proll, et al.
Journal of Virology|January 24, 2014
Divergent H7 immunogens offer protection from H7N9 virus challengeFlorian Krammer, Randy A Albrecht, Gene S Tan, et al.
Science Advances|September 13, 2023
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in miceEduard Puente-Massaguer, Kirill Vasilev, Annika Beyer, et al.
Pageof 30

Showing results (221-230 of 291) with videos related to

Sort By:
Pageof 30
The Journal of Clinical Investigation|September 7, 2018
Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominanceSean T H Liu, Mohammad Amin Behzadi, Weina Sun, et al.
Journal of Virology|December 16, 2014
The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxADavid Riegger, Rong Hai, Dominik Dornfeld, et al.
Journal of Virology|May 3, 2019
Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope ProteinMark J Bailey, Felix Broecker, Alec W Freyn, et al.
Journal of Virology|November 12, 2005
Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in miceTerrence M Tumpey, Adolfo García-Sastre, Jeffery K Taubenberger, et al.
Nature Immunology|February 14, 2017
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteinsRaffael Nachbagauer, Angela Choi, Ariana Hirsh, et al.
Mbio|June 15, 2021
An Egg-Derived Sulfated <i>N</i>-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus VaccinesJenna J Guthmiller, Henry A Utset, Carole Henry, et al.
Vaccine|December 12, 2024
A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challengeStefan Slamanig, Nicholas Lemus, Tsoi Ying Lai, et al.
Nature|September 29, 2006
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virusJohn C Kash, Terrence M Tumpey, Sean C Proll, et al.
Journal of Virology|January 24, 2014
Divergent H7 immunogens offer protection from H7N9 virus challengeFlorian Krammer, Randy A Albrecht, Gene S Tan, et al.
Science Advances|September 13, 2023
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in miceEduard Puente-Massaguer, Kirill Vasilev, Annika Beyer, et al.
Pageof 30